Endometrial Cancer Clinical Trial
Official title:
Psychosocial Benefits of Exercise in Endometrial Cancer Survivors
To determine if weekly exercise compared to stretching has an effect on fatigue, depression, and anxiety in endometrial cancer survivors.
Status | Terminated |
Enrollment | 2 |
Est. completion date | January 2013 |
Est. primary completion date | January 2013 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 70 Years |
Eligibility |
Inclusion Criteria: - 1) Female, 18 to 70 years of age with history of Stage I, II, or III endometrial cancer diagnosis occurring at least 6 months prior to study enrollment, - 2) if chemotherapy or radiation therapy was received, patient must be = 4 weeks post final primary treatment administration, - 3) if patient has undergone surgical procedure, must be = 8 weeks post-procedure or cleared by surgeon for moderate intensity walking, - 4) English speaking, - 5) medical clearance for participation provided by primary care physician or oncologist, - 6) average fatigue over the past week of =3 on a 1 to 10 Likert scale or worrying thoughts = a lot of the time or enjoy the things they used to a little/ not at all. Exclusion Criteria: - 1) metastatic or recurrent endometrial cancer, - 2) inability to ambulate without assistance, - 3) unstable angina, - 4) New York Heart Association class II, III, or IV congestive heart failure, - 5) uncontrolled asthma, - 6) having been told by a physician to only do exercise prescribed by a physician, - 7) dementia or organic brain syndrome, - 8) schizophrenia or active psychosis, - 9) participating, on average, in more than 20 minutes of physical activity on two or more days per week during the past six months, - 10) anticipates undergoing elective surgery during the duration of the intervention which would interfere with the intervention participation, - 11) does not live or work less than 50 miles from the study site, - 12) lack of transportation to the study site, - 13) plans to move residence out of the local area during the study duration, - 14) plans to travel out of the local area for more than a week during the intervention, - 15) contraindication to participation in physical activity, - 16) non-compliant with sleep apnea treatments. |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Country | Name | City | State |
---|---|---|---|
United States | Southern Illinois University School of Medicine | Springfield | Illinois |
Lead Sponsor | Collaborator |
---|---|
University of Alabama at Birmingham |
United States,
Rogers LQ, Courneya KS, Robbins KT, Rao K, Malone J, Seiz A, Reminger S, Markwell SJ, Burra V. Factors associated with fatigue, sleep, and cognitive function among patients with head and neck cancer. Head Neck. 2008 Oct;30(10):1310-7. doi: 10.1002/hed.20873. — View Citation
Rogers LQ, Hopkins-Price P, Vicari S, Markwell S, Pamenter R, Courneya KS, Hoelzer K, Naritoku C, Edson B, Jones L, Dunnington G, Verhulst S. Physical activity and health outcomes three months after completing a physical activity behavior change intervention: persistent and delayed effects. Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1410-8. doi: 10.1158/1055-9965.EPI-08-1045. Epub 2009 Apr 21. — View Citation
Rogers LQ, Malone J, Rao K, Courneya KS, Fogleman A, Tippey A, Markwell SJ, Robbins KT. Exercise preferences among patients with head and neck cancer: prevalence and associations with quality of life, symptom severity, depression, and rural residence. Head Neck. 2009 Aug;31(8):994-1005. doi: 10.1002/hed.21053. — View Citation
Rogers LQ, Markwell S, Hopkins-Price P, Vicari S, Courneya KS, Hoelzer K, Verhulst S. Reduced barriers mediated physical activity maintenance among breast cancer survivors. J Sport Exerc Psychol. 2011 Apr;33(2):235-54. — View Citation
Rogers LQ, Markwell SJ, Courneya KS, McAuley E, Verhulst S. Exercise preference patterns, resources, and environment among rural breast cancer survivors. J Rural Health. 2009 Fall;25(4):388-91. doi: 10.1111/j.1748-0361.2009.00249.x. — View Citation
Rogers LQ. Objective monitoring of physical activity after a cancer diagnosis: challenges and opportunities for enhancing cancer control. Phys Ther Rev. 2010 Jun 1;15(3):224-237. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | fatigue | 13-item multi-dimensional fatigue scale [i.e. Fatigue Symptom Inventory (FACT-F)] | Change from baseline at 12 weeks | No |
Secondary | Depression and Anxiety | 14 item Hospital Anxiety and Depression Scale (PROMIS) | Change from baseline at 8 weeks | No |
Secondary | Depression and Anxiety | 14 item Hospital Anxiety and Depression Scale (PROMIS) | Change in baseline at 12 weeks | No |
Secondary | Task self-efficacy | 4 item scale for chronic disease patients | Change in baseline at 8 weeks | No |
Secondary | Task self-efficacy | 4 item scale for chronic disease patients | Change in baseline at 12 weeks | No |
Secondary | Quality of Life | Functional Assessment of Cancer Therapy-Endometrial and the Satisfaction With Life Scale | Change in baseline at 8 weeks | No |
Secondary | Quality of Life | Functional Assessment of Cancer Therapy-Endometrial and the Satisfaction With Life Scale | Change in baseline at 12 weeks | No |
Secondary | Body Mass Index (BMI) | BMI calculated with weight and height | Change in baseline at 8 weeks | No |
Secondary | Body Mass Index (BMI) | BMI calculated with weight and height | Change in baseline at 12 weeks | No |
Secondary | Body Composition | Bioelectrical Impedance | Change in baseline at 8 weeks | No |
Secondary | Body Composition | Bioelectrical Impedance | Change in baseline at 12 weeks | No |
Secondary | Waist and Hip circumferences | the average of three measures of waist and hip (each) using a tape measure | Change in baseline at 8 weeks | No |
Secondary | Waist and Hip circumferences | the average of three measures of waist and hip (each) using a tape measure | Change in baseline at 12 weeks | No |
Secondary | fitness | submaximal fitness test | Change in baseline at 8 weeks | No |
Secondary | fitness | submaximal fitness test | Change in baseline at 12 weeks | No |
Secondary | muscle strength | back/leg dynamometer and hand grip dynamometer | Change in baseline at 8 weeks | No |
Secondary | muscle strength | back/leg dynamometer and hand grip dynamometer | Change in baseline at 12 weeks | No |
Secondary | feasibility | Number of patients recruited, Number of patients who complete the walking intervention, Number of adverse events reported, and Number of patients who complete the study | one year | Yes |
Secondary | demographic, lifestyle, and medical covariates | self-administered survey | one year | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05796518 -
Feasibility of a Patient Directed Tool to Assess Heart Health Among Endometrial Cancer Survivors
|
N/A | |
Recruiting |
NCT05489211 -
Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
|
Phase 2 | |
Active, not recruiting |
NCT03667716 -
COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.
|
Phase 1 | |
Active, not recruiting |
NCT03170960 -
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT06463028 -
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel, Serabelisib With Paclitaxel, and Paclitaxel Alone in Patients With Advanced/Recurrent Endometrial Cancer
|
Phase 2 | |
Recruiting |
NCT06036836 -
Study of Favezelimab Coformulated With Pembrolizumab (MK-4280A) in Participants With Selected Solid Tumors (MK-4280A-010)
|
Phase 2 | |
Terminated |
NCT04586335 -
Study of CYH33 in Combination With Olaparib an Oral PARP Inhibitor in Patients With Advanced Solid Tumors.
|
Phase 1 | |
Completed |
NCT03820024 -
MOtiVating Endometrial Cancer Survivors With Activity Monitors and Tailored Feedback
|
N/A | |
Active, not recruiting |
NCT05082025 -
Phase 2 Study of PI3K Inhibitor Copanlisib in Combination With Fulvestrant in Selected ER+ and/or PR+ Cancers With PI3K (PIK3CA, PIK3R1) and/or PTEN Alterations
|
Phase 2 | |
Active, not recruiting |
NCT00587886 -
Estrogen, Diet, Genetics and Endometrial Cancer
|
||
Completed |
NCT05378152 -
Assessing the Benefit of Pipelle Biopsy in Patients With Postmenopausal Bleeding and an Atrophic-appearing Cavity
|
N/A | |
Suspended |
NCT05124743 -
HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors
|
||
Recruiting |
NCT03876860 -
An Enhanced Vaginal Dilator to Reduce Radiation-Induced Vaginal Stenosis
|
N/A | |
Recruiting |
NCT04569773 -
Choosing Ovarian Preservation or Removal Before Surgery for Endometrial Cancer
|
||
Completed |
NCT04534309 -
Behavioral Weight Loss Program for Cancer Survivors in Maryland
|
N/A | |
Not yet recruiting |
NCT06366347 -
ALPINE: Maintenance Letrozole/Abemaciclib vs Pembrolizumab
|
Phase 2 | |
Not yet recruiting |
NCT05998798 -
Revealing Engagement Patterns Among Endometrial Cancer Patients
|
||
Not yet recruiting |
NCT06073184 -
Weight-loss Drug for Fertility-Sparing Treatment of Atypical Hyperplasia and Grade 1 Cancer of the Endometrium
|
Phase 2 | |
Terminated |
NCT02907073 -
Positron Emission Tomography (PET) Imaging Studies With NIS Reporter
|
Phase 1/Phase 2 | |
Completed |
NCT02413606 -
ENdometrial Cancer SURvivors' Follow-up carE (ENSURE): Less is More?
|
N/A |